Cyclerion Therapeutics, Inc. logo

CYCNCyclerion Therapeutics, Inc.

CYCN Stock Price, Valuation & Chart | Cyclerion Therapeutics, Inc.

Compare

CYCN Historical price chart

CYCN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization21.16M
PE Ratio-3.93
EPS-1.15
Trading Volume114.20K
Today's High/Low4.63/3.98
Dividend Yield0.00
52 Week High/Low8.48/1.03
Shares Outstanding4.68M
CYCN Financial Statement
CYCN Analyst ratings
CYCN Analysis & performance metrics

CYCN Company profile

Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central…

CYCN Management team

Management
Rhonda M. Chicko CPACFO
Chief Financial Officer
Regina M. Graul Ph.D.CEO
Chief Executive Officer, President & Director
Total 2 executives

CYCN Frequently asked questions

What is Cyclerion Therapeutics, Inc. (CYCN) Stock Price?

Current stock price of Cyclerion Therapeutics, Inc. (CYCN) stock is $4.520. The stock price is +8.39% higher in the session. The intraday range can be seen from this page. Volume of Cyclerion Therapeutics, Inc. (CYCN) stock is 114.20K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Cyclerion Therapeutics, Inc. (CYCN) stock price going up or down today?

The stock price of Cyclerion Therapeutics, Inc. (CYCN) can change with earnings, company news, and overall market sentiment. Cyclerion Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cyclerion Therapeutics, Inc. stock expensive at its current price?

Whether Cyclerion Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CYCN on this page is -3.93. EPS on this page is -1.15. Compare those figures with peers and growth expectations before deciding if the current Cyclerion Therapeutics, Inc. price is justified.

How has the stock price of Cyclerion Therapeutics, Inc. (CYCN) performed historically?

Historical performance for Cyclerion Therapeutics, Inc. (CYCN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CYCN reacted to past earnings and market events.

Should I buy Cyclerion Therapeutics, Inc. (CYCN) stock, at this price?

Buying Cyclerion Therapeutics, Inc. (CYCN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.